---
layout: page
title: Publications
permalink: /publications/
toggle: on
rank: 4
---
\*Authors contributed equally<br>

Members of the Morin laboratory indicated in **boldface**

## 2024

[February 2024-We published “SLIDE: Significant Latent factor Interaction Discovery and Exploration across biological domains” in Nature Methods]-

## 2023

[December 2023-We published “From bench to bedside via bytes: multi-omic immunoprofiling and integration using machine learning and network approaches” in Human Vaccines and Immunotherapeutics]

[December 2023-We contributed to “PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition”, which was published in Cell Reports Medicine]

[November 2023-We contributed to “SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased viremia and Nef antibodies in men with HIV-1”, which was published in The Journal of Infectious Diseases]

[October 2023-Jishnu gave an invited talk at BMES 2023 on, "Elucidating humoral profiles associated with Schistosomiasis pathogenesis using interpretable machine learning".]

[October 2023-Jishnu gave an invited talk at BMES 2023 on, "Significant latent factor interaction discovery and exploration across biological domains".]

[August 2023-We published “Cell Type-Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits” in Arthritis & Rheumatology]

[August 2023-We contributed to “Stability and heterogeneity in the antimicrobiota reactivity of human milk-derived immunoglobulin A”, which got published in the Journal of Experimental Medicine]

[July 2023-We contributed to “The gut protist Tritrichomonas arnold restrains virus-mediated loss of oral tolerance by modulating dietary antigen-presenting dendritic cells”, which got published in Immunity]

[June 2023-We published“Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19" in Cell Reports]

[May 2023-Jishnu gave an invited talk at FASEB Autoimmunity 2023 on , "Multi-dimensional integration of protein interactomes with genomic and molecular data discover distinct RA endotypes".]

[March 2023-Jishnu gave an invited talk at Cold Spring Harbor Laboratory Network Biology Meeting 2023 on "Uncovering immunomodulatory molecular phenotypes in infectious disease using networks".]

[April 2023-Jishnu gave an invited talk at Cold Spring Harbor Laboratory Systems Immunology Meeting 2023 on "Multi-dimensional integration of protein interactomes with genomic and molecular data discovers distinct RA endotypes".]

[April 2023-We contributed to “Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates”, which got published in the Cell Reports]

[February 2023-We contributed to “High-dimensional proteomics identifies organ injury patterns associated with outcomes in human trauma”, which got published in the The Journal of Trauma and Acute Care Surgery.]

## 2022

[October 2022-Jishnu is a Co-I at Systemic Sclerosis Center for Research and Translation which provides machine learning and network systems expertise to investigators working on SSc, SSc-ILD and SSc-PAH.]

[October 2022-Jishnu is a Co-I on the U01 Grant funded to characterize cell-intrinsic and cell-extrinsic signaling circuits in ocular disorders.]

[September 2022-Jishnu gave an invited talk at the Banff-CST Joint Transplant and Pathology Summit titled “Machine learning in clinical decision making in transplant biology”]

[August 2022-We published A supervised take on dimensionality reduction via hybrid subset selection in Patterns (Cell Press)]

[August 2022-Jishnu gave a talk at International Workshop on Scleroderma 2022 in Boston.]

[July 2022-Jishnu was invited to give a talk at ISMB 2022 on the topic “A network-based approach to identify expression modules underlying rejection in pediatric liver transplantation”]

[July 2022-Scleroderma CDMRO Award was given to Jishnu (role: Co-I)]

[July 2022-The Philadelphia Enquirer covered our very recent publication on COVID-19. Find the link to the article here! ]

[July 2022-Our work got covered in Pittsburgh's Action 4 News "4 Your Health: Studying COVID-19 antibody patterns". Have a look here]

[July 2022-Jishnu becomes a co-Director for the Systems Immunology Core (funded by NIAMS P50) which will perform machine learning and network systems analyses on multi-modal datasets in the context of SSc.]

[June 2022-Our paper Multi-Omic Admission-Based Prognostic Biomarkers Identified by Machine Learning Algorithms Predict Patient Recovery and 30-Day Survival in Trauma Patients got accepted in Metabolites]

[June 2022-Our paper High Dimensional Multi-omics Reveals Unique Characteristics of Early Plasma Administration in Polytrauma Patients with TBI got accepted in Annals of Surgery]

[June 2022-We published Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19 in Cell Press (Link)]

[May 2022-We found out that our NIAID Flu Systems Vaccinology R01 (Role: MPI, other PIs: Alcorn, Singh, Zimmerman) will be funded. Here is the link to NIH RePORTER]

[May 2022-We participated in a Pitt-Case Western CFAR application that was funded by NIAID Rustbelt (Role: co-I)]

[May 2022-We contributed to Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3  which got published in the Nature Immunology (link)]

[April 2022-Our CIHR grant (Role: co-I, PI: Konvalinka) was funded.]

[April 2022-We published a manuscript in Cell Reports Medicine demonstrating how integrating bulk RNA-seq data with protein networks can uncover signatures underlying rejection in pediatric liver transplantation. (link)]

[March 2022-Our DoD grant (Role: co-I, PIs: Lafyatis and Singh) looking at multi-omic signatures of scleroderma disease severity was funded.]

[March 2022-Our Essential Regression manuscript was published in Patterns. (link)]

## 2021

[September 2021-A NIAID R01 we participated in (Role: co-I, PIs: Rinaldo and Mailliard) looking at COVID-19 vaccine responses in HIV individuals was funded.]

[September 2021-We received a 5-year NHGRI U01 1U01HG012041-01 (Role: MPI, Other PIs: Singh, Sahni). Link on NIH Reporter ]

[August 2021-We received a 5-year NIAID New Innovator DP2 Award 1DP2AI164325-01 (Role: PI). Link on NIH Reporter]

[June 2021-An NIDDK dkNET New Investigator Pilot Program in Bioinformatics grant that we participated in has been funded (Role: co-I, PI: Joglekar).]

[June 2021-We contributed to Mechanisms of impaired lung development and ciliation in Mannosidase-1-alpha-2 (Man1a2) mutants in Frontiers in Physiology]

[April 2021-Jishnu gave a talk at the 2021 Cold Spring Harbor Systems Immunology Meeting]

[April 2021-A Department of Defense Idea Development Award grant that we participated in has been funded (Role: co-I, PI: Lafyatis).]

[March 2021-Jishnu gave a talk at the 2021 Cold Spring Harbor Networks Meeting]

## 2020

[October 2020-We published Mining for humoral correlates of HIV control and latent reservoir size in PLoS pathogens]

[September 2020-We contributed to Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study, which was published in the Journal of the American Society of Nephrology]

[August 2020-We are now supported by a Collaborative Research Agreement with the University of Brussels Center for Research In Immunology (Role: PI)!]

[July 2020-We contributed to Glucosylation by the Legionella effector SetA promotes the nuclear localization of the transcription factor TFEB, which was published in Iscience]

[July 2020-We published Mapping functional humoral correlates of protection against malaria challenge following RTS, S/AS01 vaccination in Science Translational Medicine]

[June 2020-We received a pilot Covid-19 grant from the UPMC-ITTC (Role: PI)!]

[May 2020-We contributed to Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge, which was published in Cell Reports]

[March 2020-We contributed to Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells, which was published in PLoS pathogens]

[March 2020-We contributed to Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis, which was published in the Journal of Hepatology]

[February 2020-We published Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis in The Journal of Infectious Diseases]

[January 2020-The Das Systems Immunology Lab is now supported by Center for Systems Immunology Startup Funds!]

[January 2020-The lab is now open! We look forward to exciting science in the future!]
